Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.81) by 1.23 percent. This is a 38.46 percent increase over losses of $(1.30) per share from the same period last year.